☰
Companies
▾
Companies
Calendar
Valuation
Screener
▾
Screener
Sectors
Magic Formula
Bubble Plot
Treemap
Chart Builder
Analysis
▾
Margins
Dividends
Buybacks
Countries
US vs EU P/E
IPO Tracker
Insider Buying
CEO Changes
M&A Tracker
Short Selling
Fear & Greed
AI Models
Macro
▾
EU Yield Curve
US Yield Curve
Health
▾
Diabetes
Immunology
Portfolio
▾
Portfolio
Berkshire
Buffett
More
▾
Denmark
Danish Tax
Tesla
EU XBRL Tables
Contact
Obesity
Blog
Aimovig
1 post
Teva and the approval of the migraine drug Ajovy®
23 September 2018
·
Eli Lilly
Aimovig
Ajovy